Liver fibrosis is independently associated with diabetic peripheral neuropathy in type 2 diabetes mellitus
Jinya Huang,Rumei Li,Naijia Liu,Na Yi,Hangping Zheng,Qi Zhang,Lianying Zhou,Linuo Zhou,Renming Hu,Bin Lu
DOI: https://doi.org/10.1111/jdi.13562
2021-08-08
Journal of Diabetes Investigation
Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Aims</h3><p>Non‐alcoholic fatty liver disease and type 2 diabetes mellitus are closely related and often occur simultaneously in patients. Type 2 diabetes increases the risk of diabetic peripheral neuropathy, resulting in intolerable pain and extremity amputation that reduces the quality of life. However, the role of non‐alcoholic fatty liver disease in the pathogenesis of diabetic peripheral neuropathy remains unclear. Thus, we evaluated the correlation of liver fibrosis and steatosis, which are representative histological morphologies of non‐alcoholic fatty liver disease, with diabetic peripheral neuropathy in type 2 diabetes patients.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Among the 520 patients, the prevalence of liver steatosis and fibrosis and diabetic peripheral neuropathy were 63.0% (n=328), 18.1% (n=94), and 52.1% (n=271), respectively. The prevalence of diabetic peripheral neuropathy was significantly elevated in patients with liver steatosis (55.7% vs. 44.9%, p=0.03) and fibrosis (61.5% vs. 50%, p=0.04), and it increased as liver stiffness measurement increased. Additionally, both hepatic steatosis (OR=1.48 [1.04–2.11], p=0.03) and fibrosis (OR=1.60 [1.02–2.51], p=0.04) were correlated with diabetic peripheral neuropathy. After adjusting for age, sex, weight, height, BMI, waist hip ratio, duration of T2DM, blood glucose, HOMA‐IR, blood pressure, serum lipid, liver enzyme, urea, uric acid, creatinine, and inflammatory factors, liver fibrosis remained associated with diabetic peripheral neuropathy (OR=2.24 [1.11–4.53], p=0.02).</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion</h3><p>The prevalence of diabetic peripheral neuropathy was elevated in patients with liver steatosis and fibrosis. Liver fibrosis was also independently associated with an increased risk of diabetic peripheral neuropathy.</p></section>
endocrinology & metabolism